サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1530916

デジタルバイオマーカー市場世界の産業分析、規模、シェア、成長、動向、2024～2034年予測

Digital Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 167 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デジタルバイオマーカー市場世界の産業分析、規模、シェア、成長、動向、2024～2034年予測
出版日: 2024年06月03日
発行: Transparency Market Research
ページ情報: 英文 167 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタルバイオマーカー市場-調査範囲

TMRの調査レポート「デジタルバイオマーカーの世界市場」は、2024～2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018～2034年までの世界のデジタルバイオマーカー市場の収益と予測を提供しています。また、2024～2034年までの世界のデジタルバイオマーカー市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、デジタルバイオマーカー市場を推察しました。

市場スナップショット
2023年の市場規模 21億米ドル
2034年の市場規模 433億米ドル
CAGR 31.4%

当レポートでは、世界のデジタルバイオマーカー市場の競合情勢について調査しています。世界のデジタルバイオマーカー市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界のデジタルバイオマーカー市場における参入企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 市場分析と予測、2020～2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品・ブランド分析
  • 主要M&A
  • COVID-19による産業への影響

第6章 世界の市場分析と予測：コンポーネント別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：コンポーネント別、2020～2034年
    • バイオセンサー
    • ウェアラブル
    • スマートフォンとスマートウォッチ
    • その他（インプラント等）
  • 市場の魅力分析：コンポーネント別

第7章 世界の市場分析と予測：用途別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：用途別、2020～2034年
    • 心臓血管
    • 睡眠と運動障害
    • 疼痛管理
    • 胃腸
    • 神経変性
    • 糖尿病患者
    • その他（肺など）
  • 市場の魅力：用途別分析

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：エンドユーザー別、2020～2034年
    • 医療企業
    • 医療提供者
    • 支払者
    • その他（患者等）
  • 市場の魅力分析：エンドユーザー別

第9章 世界の市場分析と予測：地域別

  • 主要調査結果
  • 市場金額予測：地域別、2020～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第10章 北米の市場分析と予測

第11章 欧州の市場分析と予測

第12章 アジア太平洋の市場分析と予測

第13章 ラテンアメリカ市場分析と予測

第14章 中東・アフリカの市場分析と予測

第15章 競合情勢

  • 市場企業-競争マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • Abbott Laboratories
    • AliveCor Inc.
    • Alphabet Inc.
    • Bayer AG
    • Biogen Inc.
    • Evidation Health, Inc.
    • Eli, Lilly and Company
    • GSK plc
    • Novartis AG
    • Pfizer Inc.
図表

List of Tables

  • Table 01: Global Digital Biomarkers Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 02: Global Digital Biomarkers Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 03: Global Digital Biomarkers Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Digital Biomarkers Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 05: North America Digital Biomarkers Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Digital Biomarkers Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 07: North America Digital Biomarkers Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 08: North America Digital Biomarkers Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 09: Europe Digital Biomarkers Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Digital Biomarkers Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 11: Europe Digital Biomarkers Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 12: Europe Digital Biomarkers Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Digital Biomarkers Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Digital Biomarkers Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 15: Asia Pacific Digital Biomarkers Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 16: Asia Pacific Digital Biomarkers Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Digital Biomarkers Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Digital Biomarkers Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 19: Latin America Digital Biomarkers Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 20: Latin America Digital Biomarkers Market Size (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Digital Biomarkers Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Digital Biomarkers Market Size (US$ Bn) Forecast, by Component, 2020-2034
  • Table 23: Middle East & Africa Digital Biomarkers Market Size (US$ Bn) Forecast, by Application, 2020-2034
  • Table 24: Middle East & Africa Digital Biomarkers Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Digital Biomarkers Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Digital Biomarkers Market Revenue (US$ Bn), by Component, 2023
  • Figure 03: Global Digital Biomarkers Market Value Share, by Component, 2023
  • Figure 04: Global Digital Biomarkers Market Revenue (US$ Bn), by Application, 2023
  • Figure 05: Global Digital Biomarkers Market Value Share, by Application, 2023
  • Figure 06: Global Digital Biomarkers Market Revenue (US$ Bn), by End-user, 2023
  • Figure 07: Global Digital Biomarkers Market Value Share, by End-user, 2023
  • Figure 08: Global Digital Biomarkers Market Value Share, by Region, 2023
  • Figure 09: Global Digital Biomarkers Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 10: Global Digital Biomarkers Market Value Share Analysis, by Component, 2023 and 2034
  • Figure 11: Global Digital Biomarkers Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Digital Biomarkers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 13: Global Digital Biomarkers Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 14: Digital Biomarkers Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Digital Biomarkers Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 16: Global Digital Biomarkers Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Digital Biomarkers Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Digital Biomarkers Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Digital Biomarkers Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Digital Biomarkers Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Digital Biomarkers Market Value Share Analysis, by Component, 2023 and 2034
  • Figure 22: North America Digital Biomarkers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 23: North America Digital Biomarkers Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 24: North America Digital Biomarkers Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Digital Biomarkers Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 26: North America Digital Biomarkers Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 27: Europe Digital Biomarkers Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Digital Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Digital Biomarkers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Digital Biomarkers Market Value Share Analysis, by Component, 2023 and 2034
  • Figure 31: Europe Digital Biomarkers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 32: Europe Digital Biomarkers Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Europe Digital Biomarkers Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Digital Biomarkers Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 35: Europe Digital Biomarkers Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 36: Asia Pacific Digital Biomarkers Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Digital Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Digital Biomarkers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Digital Biomarkers Market Value Share Analysis, by Component, 2023 and 2034
  • Figure 40: Asia Pacific Digital Biomarkers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 41: Asia Pacific Digital Biomarkers Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 42: Asia Pacific Digital Biomarkers Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Digital Biomarkers Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 44: Asia Pacific Digital Biomarkers Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 45: Latin America Digital Biomarkers Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Digital Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Digital Biomarkers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Digital Biomarkers Market Value Share Analysis, by Component, 2023 and 2034
  • Figure 49: Latin America Digital Biomarkers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 50: Latin America Digital Biomarkers Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Latin America Digital Biomarkers Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Digital Biomarkers Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 53: Latin America Digital Biomarkers Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 54: Middle East & Africa Digital Biomarkers Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Digital Biomarkers Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Digital Biomarkers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Digital Biomarkers Market Value Share Analysis, by Component, 2023 and 2034
  • Figure 58: Middle East & Africa Digital Biomarkers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 59: Middle East & Africa Digital Biomarkers Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 60: Middle East & Africa Digital Biomarkers Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Digital Biomarkers Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 62: Middle East & Africa Digital Biomarkers Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL79554

Digital Biomarkers Market - Scope of Report

TMR's report on the global digital biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global digital biomarkers market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global digital biomarkers market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the digital biomarkers market.

Market Snapshot
Market Value in 2023US$ 2.1 Bn
Market Value in 2034US$ 43.3 Bn
CAGR31.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global digital biomarkers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global digital biomarkers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global digital biomarkers market.

The report delves into the competitive landscape of the global digital biomarkers market. Key players operating in the global digital biomarkers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global digital biomarkers market profiled in this report.

Key Questions Answered in Global digital biomarkers Market Report:

  • What is the sales/revenue generated by digital biomarkers across all regions during the forecast period?
  • What are the opportunities in the global digital biomarkers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Digital Biomarkers Market - Research Objectives and Research Approach

The comprehensive report on the global digital biomarkers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global digital biomarkers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global digital biomarkers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Digital Biomarkers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Digital Biomarkers Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Digital Biomarkers Market Analysis and Forecast, by Component

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Component, 2020-2034
    • 6.3.1. Biosensors
    • 6.3.2. Wearables
    • 6.3.3. Smartphones & Smartwatches
    • 6.3.4. Others (Implantables, etc.)
  • 6.4. Market Attractiveness Analysis, by Component

7. Global Digital Biomarkers Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020-2034
    • 7.3.1. Cardiovascular
    • 7.3.2. Sleep and Movement Disorder
    • 7.3.3. Pain Management
    • 7.3.4. Gastrointestinal
    • 7.3.5. Neurodegenerative
    • 7.3.6. Diabetic
    • 7.3.7. Others (Pulmonary, etc.)
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Digital Biomarkers Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Healthcare Companies
    • 8.3.2. Healthcare Providers
    • 8.3.3. Payers
    • 8.3.4. Others (Patients, etc.)
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Digital Biomarkers Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Digital Biomarkers Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Component, 2020-2034
    • 10.3.1. Biosensors
    • 10.3.2. Wearables
    • 10.3.3. Smartphones & Smartwatches
    • 10.3.4. Others (Implantables, etc.)
  • 10.4. Market Value Forecast, by Application, 2020-2034
    • 10.4.1. Cardiovascular
    • 10.4.2. Sleep and Movement Disorder
    • 10.4.3. Pain Management
    • 10.4.4. Gastrointestinal
    • 10.4.5. Neurodegenerative
    • 10.4.6. Diabetic
    • 10.4.7. Others (Pulmonary, etc.)
  • 10.5. Market Value Forecast, by End-user, 2020-2034
    • 10.5.1. Healthcare Companies
    • 10.5.2. Healthcare Providers
    • 10.5.3. Payers
    • 10.5.4. Others (Patients, etc.)
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Component
    • 10.7.2. By Application
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Digital Biomarkers Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Component, 2020-2034
    • 11.3.1. Biosensors
    • 11.3.2. Wearables
    • 11.3.3. Smartphones & Smartwatches
    • 11.3.4. Others (Implantables, etc.)
  • 11.4. Market Value Forecast, by Application, 2020-2034
    • 11.4.1. Cardiovascular
    • 11.4.2. Sleep and Movement Disorder
    • 11.4.3. Pain Management
    • 11.4.4. Gastrointestinal
    • 11.4.5. Neurodegenerative
    • 11.4.6. Diabetic
    • 11.4.7. Others (Pulmonary, etc.)
  • 11.5. Market Value Forecast, by End-user, 2020-2034
    • 11.5.1. Healthcare Companies
    • 11.5.2. Healthcare Providers
    • 11.5.3. Payers
    • 11.5.4. Others (Patients, etc.)
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Component
    • 11.7.2. By Application
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Digital Biomarkers Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Component, 2020-2034
    • 12.3.1. Cardiovascular
    • 12.3.2. Sleep and Movement Disorder
    • 12.3.3. Pain Management
    • 12.3.4. Gastrointestinal
    • 12.3.5. Neurodegenerative
    • 12.3.6. Diabetic
    • 12.3.7. Others (Pulmonary, etc.)
  • 12.4. Market Value Forecast, by End-user, 2020-2034
    • 12.4.1. Healthcare Companies
    • 12.4.2. Healthcare Providers
    • 12.4.3. Payers
    • 12.4.4. Others (Patients, etc.)
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Component
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Digital Biomarkers Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Component, 2020-2034
    • 13.3.1. Biosensors
    • 13.3.2. Wearables
    • 13.3.3. Smartphones & Smartwatches
    • 13.3.4. Others (Implantables, etc.)
  • 13.4. Market Value Forecast, by Application, 2020-2034
    • 13.4.1. Cardiovascular
    • 13.4.2. Sleep and Movement Disorder
    • 13.4.3. Pain Management
    • 13.4.4. Gastrointestinal
    • 13.4.5. Neurodegenerative
    • 13.4.6. Diabetic
    • 13.4.7. Others (Pulmonary, etc.)
  • 13.5. Market Value Forecast, by End-user, 2020-2034
    • 13.5.1. Healthcare Companies
    • 13.5.2. Healthcare Providers
    • 13.5.3. Payers
    • 13.5.4. Others (Patients, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Component
    • 13.7.2. By Application
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Digital Biomarkers Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Component, 2020-2034
    • 14.3.1. Biosensors
    • 14.3.2. Wearables
    • 14.3.3. Smartphones & Smartwatches
    • 14.3.4. Others (Implantables, etc.)
  • 14.4. Market Value Forecast, by Application, 2020-2034
    • 14.4.1. Cardiovascular
    • 14.4.2. Sleep and Movement Disorder
    • 14.4.3. Pain Management
    • 14.4.4. Gastrointestinal
    • 14.4.5. Neurodegenerative
    • 14.4.6. Diabetic
    • 14.4.7. Others (Pulmonary, etc.)
  • 14.5. Market Value Forecast, by End-user, 2020-2034
    • 14.5.1. Healthcare Companies
    • 14.5.2. Healthcare Providers
    • 14.5.3. Payers
    • 14.5.4. Others (Patients, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Component
    • 14.7.2. By Application
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. AliveCor Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Alphabet Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Bayer AG
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Biogen Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Evidation Health, Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Eli, Lilly and Company
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. GSK plc
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Novartis AG
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Pfizer Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview